Effect of Methylphenidate Treatment on Appetite and Levels of Leptin, Ghrelin, Adiponectin, and Brain-Derived Neurotrophic Factor in Children and Adolescents with Attention Deficit and Hyperactivity Disorder.

Related Articles

Effect of Methylphenidate Treatment on Appetite and Levels of Leptin, Ghrelin, Adiponectin, and Brain-Derived Neurotrophic Factor in Children and Adolescents with Attention Deficit and Hyperactivity Disorder.

Int J Psychiatry Clin Pract. 2014 Jul 4;:1-34

Authors: Sahin S, Yuce M, Alacam H, Karabekiroglu K, Say GN, Salis O

Abstract
Abstract Objectives: We aimed to explore whether use of methylphenidate relates leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor (BDNF). In addition, the relationship between methylphenidate related weight loss in attention deficit hyperactivity disorder (ADHD) patients and these biomolecules were evaluated. Methods: Thirty ADHD patients receiving methylphenidate and 20 healthy controls were included. Leptin, ghrelin, adiponectin, and BDNF levels were measured at baseline and after 2-month treatment in both groups. Results: At baseline, leptin, ghrelin, adiponectin, and BDNF levels were similar in the ADHD and control groups. The most common adverse events occurring in the ADHD group after 2-month treatment included loss of appetite (70%) and weight loss (66.7%). A significant difference was found in body weight, BMI, and CGI scores of the ADHD patients after the treatment. While posttreatment ghrelin and adiponectin levels were significantly higher in the ADHD group, BDNF level was significantly lower. Posttreatment decrease in leptin levels was not significant. Conclusions: Leptin and BDNF were not associated with poor appetite and/or weight loss due to methylphenidate treatment. However, ghrelin and adiponectin might be biomolecules that played a role in underlying neurobiological mechanisms of methylphenidate-related appetite or weight loss.

PMID: 24994482 [PubMed – as supplied by publisher]

via http://ift.tt/1ksdAnm